Ver en Otros Idiomas

Horizon Oil Ltd


Horizon Oil Ltd ASX HZNHorizon Oil Limited (ASX:HZN) (OTCMKTS:HZNFF) is an ASX-listed petroleum exploration and production company, with a geographic focus on the Asia-Pacific region. The company currently produces over 4,000 barrels of oil per day net from its fields in New Zealand and China, which generated over US$80 million in net operating income after operating expense for the year ended 30 June 2015.  Further development candidates remain in and around these producing fields.

Horizon Oil maintains prudent policies of oil price hedging and loss of production insurance to ensure that sufficient cash flow is generated to meet the funding requirements of its growth program.

The company holds a large undeveloped reserves and contingent resource position in Western Province, onshore Papua New Guinea.  These are liquids-rich gas resources and reflect Horizon Oil’s strategy to focus on Asian gas for growth.  Gas constitute about 2/3 of the reserves and resource base.  Commercialisation pathways for the gas are emerging.

Although Horizon Oil anticipates continuing strong cash generation over the medium term from its existing producing fields, these developed reserves account for only 10% of total reserves and resource base.  The focus going forward will be on new field development, funded largely from existing production cash flow.



Reporte del Mercado Australiano del 31 de enero de 2011: Roc Oil (ASX:ROC), Horizon Oil (ASX:HZN), Petsec Energy (ASX:PSA): Empresa Conjunta Logra Hito en el Desarrollo de Campos de Petroleo en China

🕔1/31/2011 1:30:00 PM 12153

Reporte del Mercado Australiano del 31 de enero de 2011 incluye: China National Offshore Oil Company Limited (HKG:0883) (NYSE:CEO) ha aprobado el Proyecto de Inversión y el Plan de Desarrollo General para el desarrollo de los tres campos de petróleo en China; Copper Strike Limited (ASX:CSE)firmó acuerdos con China para financiar un proyecto multi-deposito en North Queensland; Jupiter recaudo A$150 millones para avanzar proyectos de mina en Sudafrica y Australia; Viralytics Limited (ASX:VLA) (PINK:VRACY)ha recibido una notificación china por la por la concesión de una patente que involucra el uso de CAVATAKTM RNA como un agente anti cancerígeno en el melanoma humano

Leer el artículo completo

123,547 Visitas al Perfil de la Empresa

  • Número de visitas: (Últimos 7 Días: 8) (Últimos 30 Días: 40) (Desde su Publicación: 9843) 

Datos de la Empresa

  • Level 6
    134 William Street
    NSW 2011, Australia
  • Teléfono
  • +61-2-9332-5000 
  • Fax
  • +61-2-9332-5050 
  • Principal Sector
  • Energy 
  • Principal Industria
  • Energy 
  • Página Principal
  • E:

Social Media